July 28, 2014 1:23 AM ET

Pharmaceuticals

Company Overview of Neocrin Company

Company Overview

As of August 1999, Neocrin Company was acquired by Novocell, Inc. Neocrin Company researches and develops minimally invasive, encapsulated cellular transplants for the treatment of diabetes. Neocrin's technology consists of proprietary immunoprotective cell encapsulation materials and cell purification techniques that the company believes will make it possible to inject insulin-producing, porcine-derived pancreatic cells (islets) into the peritoneal cavity without chronic immunosuppression, to provide near-normal blood glucose control by naturally regulating insulin release. Neocrin Company was founded by Mr. Wes Farrell in 1992. It is headquartered in Irvine, California.

31 Technology Drive

Suite 100

Irvine, CA 92618

United States

Founded in 1992

Phone:

949-727-1942

Fax:

949-727-1718

Key Executives for Neocrin Company

Neocrin Company does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Avion Pharmaceuticals, LLC United States
Ablaris Therapeutics, Inc. United States
Dermik Laboratories, Inc. United States
Cyvex Nutrition, Inc. United States
Endo Pharmaceuticals Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neocrin Company, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.